On occasion they get a data set and divide it up until there's statistical significance found, basically messing with the nature of the sample and its randomness without changing any values, they then market these benefits to the general populace. They especially do this when they are competing with cheaper generics. It's similar to the publication bias that goes on. The studies are submitted with the claims, they're just not rigorously checked or independently reproduced, there's far less scrutiny on after-market modifications after a drug has already been approved.